|
|
Volumn 48, Issue 6, 2001, Pages 499-503
|
|
A phase II study of paclitaxel plus cisplatin for advanced non-small-cell lung cancer in Japanese patients
|
|
Author keywords
Cisplatin; Non small cell lung cancer; Paclitaxel; Phase II study; Premedication
|
|
Indexed keywords
CISPLATIN;
DEXAMETHASONE;
DIPHENHYDRAMINE;
FAMOTIDINE;
PACLITAXEL;
SEROTONIN 3 ANTAGONIST;
ADENOCARCINOMA;
ADULT;
AGED;
ALLERGY;
ALOPECIA;
ARTICLE;
CANCER COMBINATION CHEMOTHERAPY;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DISEASE COURSE;
DRUG TOLERANCE;
FEMALE;
HUMAN;
HYPERSENSITIVITY;
HYPOTENSION;
JAPAN;
LUNG NON SMALL CELL CANCER;
MALE;
METASTASIS;
NAUSEA;
NEUROPATHY;
NEUTROPENIA;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
SURVIVAL RATE;
SURVIVAL TIME;
TREATMENT OUTCOME;
VOMITING;
ADULT;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARCINOMA, NON-SMALL-CELL LUNG;
CISPLATIN;
DISEASE PROGRESSION;
FEMALE;
HUMANS;
HYPOTENSION;
INFUSIONS, INTRAVENOUS;
LUNG NEOPLASMS;
MALE;
MIDDLE AGED;
NEUTROPENIA;
PACLITAXEL;
PERIPHERAL NERVOUS SYSTEM DISEASES;
SURVIVAL ANALYSIS;
TREATMENT OUTCOME;
|
|
EID: 0035214053
PISSN: 03445704
EISSN: None
Source Type: Journal
DOI: 10.1007/s002800100374 Document Type: Article |
|
Times cited : (14)
|
|
References (12)
|
